Clinical Trials Directory

Trials / Terminated

TerminatedNCT03406533

Sedation Strategies for Diagnostic Bronchoscopy

The Effect and Safety of Different Sedation Strategies for Diagnostic Bronchoscopy

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Diagnostic bronchoscopy is an invasive procedure performed to diagnose respiratory diseases. But pain has been complained by most of the patients receiving such procedures. Sedation or anesthesia was required by both of the patients and bronchoscopists. Unfortunately, no consensus has been made upon the sedation strategies. Multiple sedation approaches have been applied, such as midazolam and fentanyl, remifentanil and propofol, dexmedetomidine and propofol. The present study was designed to compare these protocols in sedation for diagnostic bronchoscopy.

Conditions

Interventions

TypeNameDescription
DRUGMidazolamMidazolam is used as a common medication for sedation in all groups.
DRUGDexmedetomidineDexmedetomidine is used for sedation in bronchoscopy with less impact on respiration.
DRUGRemifentanilRemifentanil is used for analgesia to prevent bronchoscopy induced cough.
DRUGFentanylFentanyl is another opioid drug used for analgesia to prevent bronchoscopy induced cough.
DRUGPropofolPropofol is used for sedation with high efficacy but more side effect on respiration than dexmedetomidine.

Timeline

Start date
2018-02-01
Primary completion
2018-03-30
Completion
2018-03-31
First posted
2018-01-23
Last updated
2019-06-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03406533. Inclusion in this directory is not an endorsement.